ANCA-positive crescentic glomerulonephritis in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor alpha

被引：6
|
作者：
Alkhunaizi, Ahmed M. [1 ]
Dawamneh, Mohamad F. [2 ]
机构：
[1] Johns Hopkins Aramco Healthcare, Internal Med Serv Div, Nephrol Sect, Dhahran, Saudi Arabia
[2] Johns Hopkins Aramco Healthcare, Div Pathol, Dhahran, Saudi Arabia
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2017年 / 20卷 / 11期
关键词：
HENOCH-SCHONLEIN PURPURA; RECEIVING TREATMENT; RENAL VASCULITIS; ETANERCEPT; THERAPY;
D O I：
10.1111/1756-185X.12612
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1843 / 1847
页数：5
相关论文
共 50 条
  • [31] Weight Gain in Seropositive Rheumatoid Arthritis Patients Treated With Anti-tumor Necrosis Factor (TNF) Therapy
    Alsulaim, Toka M.
    Almulla, Maryah H.
    Alotaibi, Najla S.
    AlQudari, Elham A.
    Alzahrani, Khalid A.
    Nori, Rawad M.
    Makkawy, Mosaab A.
    Alhamzi, Hanan A.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [32] Breast Lymphoma Complicating Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis
    Pattanaik, Debendra
    Koduru, Swapna
    Azouz, Abdallah
    Patil, Sadanand
    Carbone, Laura
    [J]. CLINICAL BREAST CANCER, 2011, 11 (06) : 413 - 416
  • [33] Anti-tumor necrosis factor-α monoclonal antibody therapy for rheumatoid arthritis
    Kavanaugh, AF
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (03) : 593 - +
  • [34] The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis
    Haraoui, B
    [J]. JOURNAL OF RHEUMATOLOGY, 2005, 32 : 46 - 47
  • [35] GENDER DIFFERENCES IN RHEUMATOID ARTHRITIS: EFFECT OF ANTI-TUMOR NECROSIS FACTOR THERAPY
    Gioia, Chiara
    Spinelli, Francesca
    Priori, Roberta
    Iannuccelli, Cristina
    Lucchino, Bruno
    Vestri, Annarita
    Valesini, Guido
    DI Franco, Manuela
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1650 - 1650
  • [36] Weight changes in rheumatoid arthritis patients on anti-tumor necrosis factor agents
    Syed, Reema H.
    Gilliam, Brooke E.
    Pepmueller, Peri H.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4284 - 4284
  • [37] Golimumab Use and Sustained Clinical Response in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-Tumor Necrosis Factor Alpha Agents
    Smolen, Josef
    Kay, Jonathan
    Landewe, Robert
    Matteson, Eric L.
    Gaylis, Norman B.
    Wollenhaupt, J.
    Murphy, Frederick T.
    Zamani, O.
    Zhou, Yiying
    Hsia, Elizabeth C.
    Doyle, Mittie K.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S880 - S880
  • [38] Genetic predictors of response to anti-tumor necrosis factor drugs in rheumatoid arthritis
    Tan, Rachael
    Barton, Anne
    [J]. RHEUMATOLOGY REPORTS, 2009, 1 (01) : 1 - 4
  • [39] Graves' Disease, Rheumatoid Arthritis, and Anti-Tumor Necrosis Factor-α Therapy
    Shin, Jae Il
    Kim, Min Jung
    Lee, Jae Seung
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (02) : 449 - 450
  • [40] Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-α therapy
    Kaur, PP
    Derk, CT
    Chatterji, M
    Dehoratius, RJ
    [J]. JOURNAL OF RHEUMATOLOGY, 2004, 31 (08) : 1663 - 1665
12345